Thompson SM
Department of Psychiatry, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. scott.m.thompson@cuanschutz.edu.
PreprintPsilocybin
Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and Colorado
ArticleLSD
Characterizing non-hallucinogenic psychedelics beyond the head twitch response: phenotypic fingerprinting of lisuride and LSD.
ArticleLSD
Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice.
PreprintLSD
Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice
ArticleKetamine
Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder.
ArticlePsilocybin
Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
ArticlePsychedelics
Correction: Optimizing psychedelic compounds for neuropsychiatric therapy.
ArticlePsychedelics
Optimizing psychedelic compounds for neuropsychiatric therapy.
ArticlePsilocybin